Viewing StudyNCT00501332



Ignite Creation Date: 2024-05-05 @ 6:35 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00501332
Status: UNKNOWN
Last Update Posted: 2007-12-24
First Post: 2007-07-12

Brief Title: Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC Docetaxel Adriamycin Cyclophosphamide Chemotherapy
Sponsor: Maxygen Holdings Ltd
Organization: Maxygen Holdings Ltd

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Chemotherapy-Induced Neutropenia
Keywords:
Name View
neutropenia View
breast View
cancer View
chemotherapy View